$VSTM $1.93 EOD and still going AH. has ~$1.90 cash per share, (37m O/S as of last 10K, cash and cash equivalents $81m, Q/Q cash burn was ~$6M, $10.8M liabilities), opened a $25M lone facility with Hercules to fund their P3 asset, Phase 3 data due 1H 2017 (Duvelisib - DUO , Cancer - relapsed/refractory chronic lymphocytic leukemia (CLL)), tutes had aggregated shares on 12/31/2016 of 9.49M, big gap down from $5.67 on the chart 18 months ago. we're at cash right now - EV is not priced in. could move very nice - especially if volume keeps coming